This Week In FDA History - Aug. 21, 2002
August 21, 2002:
FDA announces an initiative to modernize the regulation of pharmaceutical manufacturing and product quality. Its goals are to focus on the greatest public health risks, to ensure that quality standards do not impede innovation, and to apply a consistent approach across the agency.
|FDA in 2006
|In the four years since the initiative was announced, the FDA has completed its assessment of this regulatory area, called the current Good Manufacturing Practices (cGMP) program. This assessment helped the agency focus on quality systems and risk management approaches to regulating the manufacture of medicines. The next major milestone of the initiative is a public workshop scheduled for Feb. 28-March 2, 2007, with||
these objectives: To explore FDA's quality initiatives and share progress made; to provide updates from the FDA?s Council on Pharmaceutical Quality, with a focus on implementation challenges and remaining issues; to seek input and recommendations from stakeholders; to provide updates from the FDA's Council on Pharmaceutical Quality, with a focus on implementation challenges and remaining issues to seek input and recommendations from stakeholders.